Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study

Exp Gerontol. Jan-Mar 2002;37(2-3):445-53. doi: 10.1016/s0531-5565(01)00212-1.


Results from a previous longitudinal study, the Swedish OCTO-Immune study, indicated that the combination of higher CD8 peripheral blood lymphocytes (PBLs), decreased CD4 PBLs, and poor proliferative response to mitogenic stimulation in very old humans were associated with an increased 2 year mortality. In follow up studies this combination of immune parameters was significantly associated with a CD4/CD8 ratio less than one and positive IgG serologic titers to cytomegalovirus (CMV). The present study, the Swedish NONA-Immune study, was an extension of that study, using a new sample of the very old. The results of this study confirmed the results of the previous study and extended the surface marker profile of the PBLs, indicating that the CD4/CD8 ratio change is associated with increased CD8 cells, decreased CD4 cells, and lymphocyte activation. The predominant phenotypes of the CD3+CD8+ cells were CD27-, CD28-, CD56+, and CD57+, CD45RA+, and double marked CD45RA+RO+. As in the OCTO study, the NONA-Immune data indicated that the changes are associated significantly with seropositive responses to CMV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / blood
  • Aging / immunology*
  • Antibodies, Viral / blood
  • Biomarkers
  • CD3 Complex
  • CD4-CD8 Ratio
  • CD8-Positive T-Lymphocytes / cytology*
  • Carrier State
  • Cytomegalovirus / immunology
  • Cytomegalovirus Infections / blood
  • Cytomegalovirus Infections / epidemiology
  • Cytomegalovirus Infections / immunology*
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Prevalence
  • Sweden / epidemiology
  • T-Lymphocyte Subsets / cytology


  • Antibodies, Viral
  • Biomarkers
  • CD3 Complex
  • Immunoglobulin G